Welcome to LookChem.com Sign In|Join Free
  • or
1-(5-chloro-4-fluoro-2-methoxyphenyl)ethanone is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1300730-59-9

Post Buying Request

1300730-59-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1300730-59-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1300730-59-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,0,0,7,3 and 0 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1300730-59:
(9*1)+(8*3)+(7*0)+(6*0)+(5*7)+(4*3)+(3*0)+(2*5)+(1*9)=99
99 % 10 = 9
So 1300730-59-9 is a valid CAS Registry Number.

1300730-59-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(5-Chloro-4-fluoro-2-methoxyphenyl)ethanone

1.2 Other means of identification

Product number -
Other names 1-(5-Chloro-2-methylphenyl)-3-benzoyl-2-thiourea

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1300730-59-9 SDS

1300730-59-9Downstream Products

1300730-59-9Relevant academic research and scientific papers

IMIDAZOLE DERIVATIVES AS IDO INHIBITORS

-

, (2011/06/11)

Presently provided are IDO inhibitors of general formulae (VII), (VIII) as shown below and pharmaceutical compositions thereof, useful for modulating an activity of indoleamine 2,3-dioxygenase; treating indoleamine 2,3-dioxygenase (IDO) mediated immunosuppression; treating a medical conditions that benefit from the inhibition of enzymatic activity of indoleamine-2,3-dioxygenase; enhancing the effectiveness of an anti-cancer treatment comprising administering an anti-cancer agent; treating tumor-specific immunosuppression associated with cancer; and treating immunosupression associated with an infectious disease.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1300730-59-9